Reversible serum carcinoembriogenic antigen (CEA) elevation due to orlistat use: a case report

Reversible serum carcinoembriogenic antigen (CEA) elevation due to orlistat use: a case report

Bibliographic Details
Main Authors:	Gustavo dos Santos Fernandes, Atur Katz, Aknar Calabrich, Paulo M. Hoff
Format:	Article
Language:	English
Published:	Elsevier España 2010-01-01
Series:	Clinics
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010000600013

Similar Items

Deficiência de ferro no paciente com câncer
by: Aknar F. C. Calabrich, et al.

Complete Radiologic Response in an Anaplastic Oligodendroglioma Treated with Temozolomide and Bevacizumab
by: Artur Katz, et al.
Published: (2009-03-01)

Role of serum carcinoembryonic antigen (CEA) as a tumor marker in breast cancer
by: Shahbaz Habib Faridi, et al.
Published: (2014-01-01)

The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels
by: Xie HL, et al.
Published: (2019-08-01)

The Carcinoembryonic Antigen (CEA): Past, Present, and Future
by: Phil Gold, et al.
Published: (2020-12-01)

Assessment of Elevated Serum Tumor Markers Carcinoembryonic Antigen (CEA) and Cancer Antigen 15-3 (CA15-3) among Patients with Different Subtypes of Metastatic Breast Cancer
by: Ali Taghizadeh, et al.
Published: (2019-01-01)

Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations
by: Yuan Gao, et al.
Published: (2017-07-01)

The role of orlistat in management of obesity
by: Samuel Oetoro
Published: (2022-10-01)

Obesity management: Update on orlistat
by: Belinda S Drew, et al.
Published: (2008-01-01)

Colorectal hyperplasia and dysplasia due to human carcinoembryonic antigen (CEA) family member expression in transgenic mice.
by: Carlos H F Chan, et al.
Published: (2007-01-01)

Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.
by: Stern, N, et al.
Published: (2005)

Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review
by: Li Chen, et al.
Published: (2020-10-01)

Orlistat for overweight subjects with nonalcoholic steatohepatitis.
by: Dowman, J, et al.
Published: (2009)

Acute oxalate nephropathy associated with orlistat
by: Youshay Humayun, et al.
Published: (2016-04-01)

Orlistat in the prevention of diabetes in the obese patient
by: Marcio C Mancini, et al.
Published: (2008-04-01)

Reversible Sensorineural Hearing Loss due to Pachymeningitis Associated with Elevated Serum MPO-ANCA
by: Eun-Jung Lim, et al.
Published: (2011-09-01)

Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
by: Nolan, K, et al.
Published: (1999)

Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
by: Seung E. Cha, et al.
Published: (2021-01-01)

Multivariate Analysis of Prognostic Determinants for Colorectal Cancer Patients with High Preoperative Serum CEA Levels: Prognostic Value of Postoperative Serum CEA Levels
by: Cheng-Jen Ma, et al.
Published: (2006-12-01)

Development and validation by statistical treatment of stability indicating RP-HPLC method for quantification of Orlistat in Orlistat-loaded solid dispersion
by: Kiran Singh Sharma, et al.
Published: (2021-02-01)

Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1
by: Jinghan Wang, et al.
Published: (2024-01-01)

Orlistat improves endothelial function in obese adolescents
Published: (2013-12-01)

Evaluation of efficacy and safety of orlistat in obese patients
by: Suyog S Jain, et al.
Published: (2011-01-01)

The Effect of Orlistat on Sterol Metabolism in Obese Patients
by: Yu-Jin Kwon, et al.
Published: (2022-02-01)

Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
by: Yingbo Shao, et al.
Published: (2015-01-01)

The importance of preoperative elevated serum levels of CEA and CA15-3 in patients with breast cancer in predicting its histological type.
by: J Słonina, et al.
Published: (2010-06-01)

A case of allergic bronchopulmonary mycosis due to Schizophyllum commune with elevated serum carcinoembryonic antigen levels
by: Mika Yamaguchi, et al.
Published: (2022-01-01)

The Association of Carcinoembryonic Antigen (CEA) and Air Pollutants—A Population-Based Study
by: Yi-Jen Fang, et al.
Published: (2022-03-01)

CEA vaccines
by: Anchit Bhagat, et al.
Published: (2023-12-01)

Delay to CEA
by: Christopher Nwatuzor, et al.
Published: (2024-01-01)

The effect of orlistat treatment on cardiovascular novel inflammatory biomarkers
by: Zafer Yalim, et al.
Published: (2020-06-01)

ORLISTAT IN COMBINATION THERAPY OF OBESITY AND TYPE 2 DIABETES
by: A. M. Mkrtumyan, et al.
Published: (2017-12-01)

High sensitivity of Giardia duodenalis to tetrahydrolipstatin (orlistat) in vitro.
by: Juliane Hahn, et al.
Published: (2013-01-01)

The effect of orlistat on body weight in obese Czech adults
by: Pavlík Vladimír, et al.
Published: (2013-10-01)

Characterization of gastric adenocarcinoma cell lines established from CEA424/<it>SV40 T antigen</it>-transgenic mice with or without a human <it>CEA </it>transgene
by: Hatz Rudolf A, et al.
Published: (2006-03-01)

Influence of orlistat therapy on serum insulin level and morphological and functional parameters of peripheral arterial circulation in obese patients
by: Hajduković Zoran, et al.
Published: (2005-01-01)

Association of T Stage and Serum CEA Levels in Determining Survival of Rectal Cancer
by: Shengwen Wu, et al.
Published: (2020-01-01)

Clinical Associations of Preoperative and Postoperative Serum CEA and Lung Cancer Outcome
by: Zonglin Jiao, et al.
Published: (2021-10-01)

Reversible, regional ST‐segment elevation due to chylothorax
by: Sarah H. Brown, et al.
Published: (2022-01-01)

The role of serum IL-6 in colorectal cancer patients and it’s relationship with serum CEA level
by: Batool H. Al-Ghurabi, et al.
Published: (2010-01-01)